This inventor holds 6 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Curamys Inc., Shaperon Inc., Korea University Research and Business Foundation. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3 
2 out of 4 
1 out of 1,282 
Years Active: 2016-2024
Title: Innovations of Seung-Yong Seong in Gene and Cell Therapy
Introduction
Seung-Yong Seong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of gene and cell therapy, holding a total of six patents. His work focuses on utilizing cell fusion technology to address various medical challenges.
Latest Patents
Seung-Yong Seong's latest patents revolve around gene and cell therapy using cell fusion technology. His inventions involve cells that overexpress hemagglutinin neuraminidase (HN) and fusion (F) proteins. These innovations enhance cell fusion with other cells, restore damaged cells through fusion, and facilitate the transfer of normal genes. The clinical application of these technologies is expected to reduce damage in cells affected by neurodegenerative and muscular diseases.
Career Highlights
Throughout his career, Seung-Yong Seong has worked with notable companies such as Curamys Inc. and Shaperon Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and therapeutic innovations.
Collaborations
Seung-Yong Seong has collaborated with esteemed colleagues, including Jung-Joon Sung and Hee-Woo Lee. These partnerships have fostered a collaborative environment that enhances research and development in gene and cell therapy.
Conclusion
Seung-Yong Seong's innovative work in gene and
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile